Celltrion
068270.KS
#648
Rank
C$42.19 B
Marketcap
$203.72
Share price
2.97%
Change (1 day)
37.47%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : C$19.77 B

According to Celltrion 's latest financial reports the company's total assets are C$19.77 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31C$6.34 B5.06%
2021-12-31C$6.03 B2.42%
2020-12-31C$5.89 B36.18%
2019-12-31C$4.32 B1.08%
2018-12-31C$4.28 B10.2%
2017-12-31C$3.88 B20.84%
2016-12-31C$3.21 B3.03%
2015-12-31C$3.12 B26.88%
2014-12-31C$2.45 B23.18%
2013-12-31C$1.99 B20%
2012-12-31C$1.66 B34.75%
2011-12-31C$1.23 B20.32%
2010-12-31C$1.02 B100.5%
2009-12-31C$0.51 B4.21%
2008-12-31C$0.49 B654.97%
2007-12-31C$65.04 M